The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST)
.If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Multicolor flow cytometric analysis of CD100 expression on human peripheral blood cells. Human peripheral blood was treated with BD PharmLyse™ Lysing Buffer to lyse erythrocytes. The leucocytes were washed and stained with Alexa Fluor 488 Mouse Anti-Human CD4 (Cat. No. 557695; Upper Panels) and BD Horizon™ V450 Mouse Anti-Human CD19 (Cat. No. 560353; Lower Panels) antibodies, and with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat No. 557714; Left Panels) or Alexa Fluor® 647 Mouse Anti-Human CD100 (Cat. No. 564873; Right Panels). The two-color flow cytometric contour plots showing the correlated expression of CD4 or CD19 versus CD100 (or Ig Isotype control staining) were derived ffrom gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometric analysis was performed using a BD LSRFortessa™ Flow Cytometer System.
Multicolor flow cytometric analysis of CD100 expression on human peripheral blood cells. Human peripheral blood was treated with BD PharmLyse™ Lysing Buffer to lyse erythrocytes. The leucocytes were washed and stained with Alexa Fluor 488 Mouse Anti-Human CD4 (Cat. No. 557695; Upper Panels) and BD Horizon™ V450 Mouse Anti-Human CD19 (Cat. No. 560353; Lower Panels) antibodies, and with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat No. 557714; Left Panels) or Alexa Fluor® 647 Mouse Anti-Human CD100 (Cat. No. 564873; Right Panels). The two-color flow cytometric contour plots showing the correlated expression of CD4 or CD19 versus CD100 (or Ig Isotype control staining) were derived ffrom gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometric analysis was performed using a BD LSRFortessa™ Flow Cytometer System.
Multicolor flow cytometric analysis of CD100 expression on human peripheral blood cells. Human peripheral blood was treated with BD PharmLyse™ Lysing Buffer to lyse erythrocytes. The leucocytes were washed and stained with Alexa Fluor 488 Mouse Anti-Human CD4 (Cat. No. 557695; Upper Panels) and BD Horizon™ V450 Mouse Anti-Human CD19 (Cat. No. 560353; Lower Panels) antibodies, and with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat No. 557714; Left Panels) or Alexa Fluor® 647 Mouse Anti-Human CD100 (Cat. No. 564873; Right Panels). The two-color flow cytometric contour plots showing the correlated expression of CD4 or CD19 versus CD100 (or Ig Isotype control staining) were derived ffrom gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometric analysis was performed using a BD LSRFortessa™ Flow Cytometer System.
Multicolor flow cytometric analysis of CD100 expression on human peripheral blood cells. Human peripheral blood was treated with BD PharmLyse™ Lysing Buffer to lyse erythrocytes. The leucocytes were washed and stained with Alexa Fluor 488 Mouse Anti-Human CD4 (Cat. No. 557695; Upper Panels) and BD Horizon™ V450 Mouse Anti-Human CD19 (Cat. No. 560353; Lower Panels) antibodies, and with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat No. 557714; Left Panels) or Alexa Fluor® 647 Mouse Anti-Human CD100 (Cat. No. 564873; Right Panels). The two-color flow cytometric contour plots showing the correlated expression of CD4 or CD19 versus CD100 (or Ig Isotype control staining) were derived ffrom gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometric analysis was performed using a BD LSRFortessa™ Flow Cytometer System.
Multicolor flow cytometric analysis of CD100 expression on human peripheral blood cells. Human peripheral blood was treated with BD PharmLyse™ Lysing Buffer to lyse erythrocytes. The leucocytes were washed and stained with Alexa Fluor 488 Mouse Anti-Human CD4 (Cat. No. 557695; Upper Panels) and BD Horizon™ V450 Mouse Anti-Human CD19 (Cat. No. 560353; Lower Panels) antibodies, and with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat No. 557714; Left Panels) or Alexa Fluor® 647 Mouse Anti-Human CD100 (Cat. No. 564873; Right Panels). The two-color flow cytometric contour plots showing the correlated expression of CD4 or CD19 versus CD100 (or Ig Isotype control staining) were derived ffrom gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometric analysis was performed using a BD LSRFortessa™ Flow Cytometer System.
Multicolor flow cytometric analysis of CD100 expression on human peripheral blood cells. Human peripheral blood was treated with BD PharmLyse™ Lysing Buffer to lyse erythrocytes. The leucocytes were washed and stained with Alexa Fluor 488 Mouse Anti-Human CD4 (Cat. No. 557695; Upper Panels) and BD Horizon™ V450 Mouse Anti-Human CD19 (Cat. No. 560353; Lower Panels) antibodies, and with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat No. 557714; Left Panels) or Alexa Fluor® 647 Mouse Anti-Human CD100 (Cat. No. 564873; Right Panels). The two-color flow cytometric contour plots showing the correlated expression of CD4 or CD19 versus CD100 (or Ig Isotype control staining) were derived ffrom gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometric analysis was performed using a BD LSRFortessa™ Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The A8 monoclonal antibody specifically binds to CD100 which is also known as Semaphorin-4D (SEMA4D). CD100 is a 150 kDa type I transmembrane glycoprotein that belongs to the semaphorin family. CD100 is widely expressed in the nervous and immune systems. Although it is expressed on T cells, its expression is significantly upregulated on activated T cells. It is also expressed on NK cells, B cells, and monocytes. CD100 is an adhesion molecule that functions as a signaling molecule which plays a role in lymphocyte activation. CD100 interaction with CD72 enhances B cell signaling and ultimately promotes B cell activation and survival.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.